Pfizer forms licensing agreement with Seattle Genetics

January 7, 2011
Pfizer has paid Seattle Genetics $8 million to license its antibody technology, Seattle Genetics said Thursday.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>
Related Terms:
Branded
Pharmacist Society
Supplier News
Latest News
Specialty Pharmacy
Pharmacy
BOTHELL
Seattle
Pfizer
Seattle Genetics
Company Location
Company Technology
ADC technology
antibodies
Antibody
Biology
Biotechnology
Cancer treatments
Dacetuzumab
Figitumumab
Immune system
Immunology
Medicine
Monoclonal antibodies
Washington
© 2012 Drug Store News. All Rights Reserved.